circRNA basic information
circBase ID: hsa_circ_0074158
Name: hsa_circ_CTNNA1
Synonym: circ_0074158
Host Gene: CTNNA1
Genomic location(hg19): chr5:138117611-138119061:+
Genomic location(hg38): chr5:138781922-138783372:+
Subcellular localization: nucleus and cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005229
MONDO name: bacterial infectious disease with sepsis
Disease details: sepsis
Disease DO ID:
0040085
Disease MeSH ID:
D016470
Disease NCIt ID:
-
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

lung tissue; serum

Cell lines:

HUVECs

In vivo animal model:

other disease animal model

circRNA-disease information
Expression pattern:
UP
Associated gene: EIF4A3, CTNNA1
Associated microRNA: -
Biological function: impairs endothelial barrier function and increases endothelial hyperpermeability in sepsis
Molecular mechanism: binds the RBP EIF4A3 to reduce CTNNA1 mRNA stability and alpha-catenin production
Biological pathway or process:

mRNA stability (inhibits); other pathway/process (other)

Detected method:
Q
S
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; RT-qPCR; Western Blot; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Actinomycin D / DRB Stability Assay; Transfection; IF (Immunofluorescence); In Vivo Animal Model; H&E Staining; ELISA; Survival Analysis; Bioinformatics Analysis; RNA-seq

Clinical significance:

high expression in sepsis patients, correlated with disease severity and prognosis

Description:

hsa_circ_0074158 is up-regulated in sepsis and aggravates sepsis-induced endothelial barrier dysfunction. It directly binds the RBP EIF4A3 and post-transcriptionally destabilizes its host gene CTNNA1 mRNA, reducing alpha-catenin production and increasing endothelial hyperpermeability.

Confidence score:

0.8382

Other information
Title:

Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.

Journal: Frontiers in immunology
Published: 2025
PubMed ID: 41058681
Study type:

combined biological and clinical study

Data availability: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1621095/full#supplementary-material
Code availability: -